Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

OBJECTIVE: To investigate limiting factors of American College of Rheumatology (ACR)/EULAR Boolean remission in rheumatoid arthritis (RA), and compare patients who fulfil the criteria to patients who only partly fulfil the criteria, with respect to imaging inflammation and biologic disease modifying...

Descripción completa

Detalles Bibliográficos
Autores principales: Paulshus Sundlisæter, Nina, Sundin, Ulf, Aga, Anna-Birgitte, Sexton, Joseph, Hammer, Hilde Berner, Uhlig, Till, Kvien, Tore K, Haavardsholm, Espen A, Lillegraven, Siri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804675/
https://www.ncbi.nlm.nih.gov/pubmed/35091463
http://dx.doi.org/10.1136/rmdopen-2021-002013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804675/
https://www.ncbi.nlm.nih.gov/pubmed/35091463
http://dx.doi.org/10.1136/rmdopen-2021-002013

Ejemplares similares